Cellular Glycan Modification by B3GAT1 Broadly Restricts Influenza Virus Infection

Researchers conducted a whole-genome CRISPR activation screen with influenza B virus (IBV). A top hit from their screen, beta-1,3-glucuronyltransferase 1, effectively blocked IBV infection.